Tweenvest Stocks

Exousia Bio, Inc. (OTCPK: LMMY)

Health Care · Biotechnology · US

$0.02

+5.62% today · -90.6% 1Y

Exousia Bio, Inc. (OTCPK: LMMY) operates in the Biotechnology industry within the Health Care sector. The company is valued at $887.25K and employs 2 people.

Over the last twelve months the share price has lost 90.6%, trading between 0.01 and 0.94.

Tweenvest scores Exousia Bio, Inc. across four factors: quality 39/100, value 53/100. Its strongest factor is value.

LMMY price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$887.25K
Revenue (TTM)
$0.00
P/E
—
EPS
-0.01
Dividend yield
—
Beta (5Y)
-8.87
52-week high
$0.94
52-week low
$0.01
Avg volume (3M)
—
Shares outstanding
52.50M
Employees
2
Next earnings
—

About Exousia Bio, Inc.

Exousia Bio, Inc. is a biotechnology company that designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026.

ISIN
US50172J1051
Founded
2022
Listed since
Oct 1, 2024
Exchange
Pink Sheets LLC
Currency
USD
CompanyMarket capPriceDay
Tessera Defense and Homeland Security Inc.NYSEAM: HLSQ$982.80K$0.29-19.03%
Premier Biomedical, Inc.OTCPK: BIEI$929.43K$0.00+10.00%
Aptahem AB (publ)NGM: APTA$906.66KSkr0.35-3.06%
Epigenomics AGDB: ECX$898.20K€0.91-4.21%
Yubo International Biotech LimitedOTCPK: YBGJ$886.19K$0.01-51.85%
Agentix Corp.OTCPK: AGTX$801.34K$——
CERo Therapeutics Holdings, Inc.OTCPK: CERO$797.17K$0.01-4.55%
Hindustan Bio Sciences LimitedBSE: 532041$782.54KRs7.35+1.80%

Browse every Biotechnology company →

Figures last refreshed Oct 4, 2026.